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Introduction: Currently, cancer is still a main cause for 
human deaths, generally due to late detection and low 
effectiveness of existing diagnostic and therapeutic 
technologies. Studies [Sailor MJ. Adv Mater. 
2012;24:3779-3802.] are now conducted on developing 
theranostics which combine cancer diagnostic and 
therapeutic functions in single nanodevices. 
Multifunctional nanodevices, which integrate sensing, 
imaging and therapeutic modalities in a single 
nanostructure, are investigated for new theranostics. 
Although considerable efforts have been made, the smart 
combination of two or more distinct nanoparticles into a 
functional structure is still a major challenge. For 
theranostics, gold nanorods (AuNR) are attractive for a 
few reasons. Porous silica coating can form on AuNRs to 
improve their stability and biocompatibility and also to 
provide rich silanol group for attaching targeting ligands 
for cancer detection. Furthermore, porous silica is a good 
vehicle for drug delivery. It is well known that surface 
enhanced Raman scattering (SERS) is highly sensitive to 
the assembly state of Au nanostructure [Wang Y. Chem 
Rev. 2012;113:1391-1428.]. In this investigation, a core-
shell structured theranostics which had an AuNR core and 
a mesoporous silica shell decorated with gold 
nanoparticles (AuNPs) was fabricated and studied. The 
nanodevice was expected to possess multifunctions for 
anticancer applications. 
Methods: Core-shell structured AuNR@mSiO2@Au NPs 
were made in a three-step process. First, AuNRs were 
synthesized using a seed-mediated growth method with 
binary surfactants. Second, AuNR@mSiO2 NPs were 
produced using a sol-gel and surfactant-removal method 
while mesopores in silica shell were loaded with 
anticancer drug doxorubicin hydrochloride (DOX). Third, 
AuNPs (~5 nm in diameter) were assembled on surface of 
AuNR@mSiO2 NPs to obtain AuNR@mSiO2@Au NPs 
with a core@shell@shell structure. For cancer detection, 
rhodamine 6G (R6G, a Raman reporter) was embedded in 
NPs. Drug loading and release of this nanodevice were 
studied. The SERS activity of NPs was measured using 
Raman spectroscopy. The biological performance, 
including cancer cell targeting, in vitro SERS detection 
and photothermal therapy, was studied using Hela and 
MCF-7 cancer cells. 
Results: As-synthesized AuNRs showed a monodispersed 
morphology (20 nm in diameter and 75 nm in length). 
TEM analysis showed that the silica shell of core-shell 
structured AuNR@mSiO2 NPs had a thickness of around 
25 nm. After removal of the template (surfactants 
adsorbed on the surface of AuNR), a mesoporous 
structure of the silica shell was created on AuNRs. 
Through conjugation with amino groups, AuNR@mSiO2 
were positively charged, which facilitated the attachment 
of negatively charged Au NPs via electrostactic 
adsorption. Many AuNPs (~5 nm in diameter) were 
deposited on the surface of AuNR@mSiO2 NPs (Fig.1a). 
These AuNPs would be hotspots which would enable high 
SERS activity for cancer detection. Fig.1b displays SERS 
spectra. The intensity of Raman signals of R6G were 
significantly enhanced when it was embedded in 
AuNR@mSiO2@Au NPs even at very low R6G 
concentration (10-5M). The photothermal effect arising 
from the AuNR core of AuNR@mSiO2@Au NPs was 
also studied. When irradiated with a 780 nm laser beam, 
AuNR@mSiO2@Au immediately converted light to heat, 
increasing the temperature of AuNR@mSiO2@Au 
suspensions. The temperature increase was up to 5 C 
even at low NP concentration and low laser intensity. 
Drug release from AuNR@mSiO2@Au was studied at 
37C with or without laser irradiation. Under laser 
irradiation, DOX release was activated, providing 
chemotherapy (Fig.2a). TEM analysis for Hela cells 
incubated with NPs showed that AuNR@mSiO2@Au NPs 
were taken up by Hela cells, trapped in endosomes and 
maintained their original morphology, indicating the high 
specific targeting and integrity of NPs. Live/dead cell 
viability assay of cancers cells incubated with NPs and 
after laser irradiation showed that the NPs produced 










Fig. 1. Structure and property of AuNR@mSiO2@Au 










Fig. 2. Performance of AuNR@mSiO2@Au 
theranostics: (a) In vitro drug release from 
AuNR@mSiO2@Au at 37C, (b) Hela cells with 
internalized AuNR@mSiO2@Au 
Conclusions: Core-shell and multishell structured 
AuNR@mSiO2@Au NPs as new theranostics were made. 
AuNPs on the outer surface of NPs would provide high-
sensitivity SERS signals while AuNR core could generate 
photothermal effect. The stored drug was trigger-released 
under laser irradiation. The nanodevice exhibited good 
targeting ability and combined anti-cancer therapy. 
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